Venous thromboembolism is a common complication of asparaginase-based chemotherapy regimens for the treatment of acute lymphoblastic

 

Abstract

Venous thromboembolism is a common complication of asparaginase-based chemotherapy regimens for the treatment of acute lymphoblastic leukemia. Thrombosis associated with asparaginase administration poses a number of specific and often clinically challenging management decisions. This review provides guidance on the prevention and treatment of thrombosis associated with asparaginase in adults including discussions on antithrombin repletion, pharmacologic thromboprophylaxis, cerebral venous thrombosis, and therapeutic anticoagulation.

PMID: 31999063 [PubMed - in process]

13:23

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

13:23

In reply to this message

pubmed: caandvteortroorpul

Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.

Related Articles

Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.

Br J Haematol. 2020 Jan 29;:

Authors: Martinez C, Katholing A, Wallenhorst C, Cohen AT